Drugs involved in Kentucky drug poisoning deaths and relation with antecedent controlled substance prescription dispensing

• Published in: Substance abuse treatment, prevention and policy prevention and policy, 2023-09, Vol.18 (1), p.1-53, Article 53
• Main Authors: Freeman, Patricia R, McAninch, Jana, Dasgupta, Nabarun, Oyler, Douglas R, Slavov, Krassimir, Collins, Candice, Hargrove, Sarah, Freeman, Edward, Miracle, Dustin, Slavova, Svetla
• Format: Article
• Language: English
• Subjects: Benzodiazepines; Cocaine; Controlled substances; Dispensing; Drug overdose; Drug poisoning; Drug stores; Drugs; Fatalities; FDA approval; Fentanyl; Generic products; Health aspects; Hispanic people; Methadone; Mortality; Narcotics; Opioid; Overdose; Overdose death; Pharmacists; Poisoning; Prescription drugs; Prescription monitoring program; Software; Stimulant; Stimulants; Surveillance; Vital statistics
• ISSN: 1747-597X; 1747-597X
• DOI: 10.1186/s13011-023-00561-y

The shift from prescription to illicit drugs involved in drug poisoning deaths raises questions about the current utility of prescription drug monitoring program (PDMP) data to inform drug poisoning (overdose) prevention efforts. In this study, we describe relations between specific drugs involved in Kentucky drug poisoning deaths and antecedent controlled substance (CS) dispensing. The study used linked death certificates and PDMP data for 2,248 Kentucky resident drug poisoning deaths in 2021. Death certificate literal text analysis identified drugs mentioned with involvement (DMI) in drug poisoning deaths. We characterized the concordance between each DMI and the CS dispensing history for this drug at varying timepoints since 2008. Overall, 25.5% of all decedents had dispensed CS in the month before fatal drug poisoning. Over 80% of decedents were dispensed opioid(s) since 2008; the percentage was similar regardless of opioid involvement in the poisoning death. One-third of decedents had dispensed buprenorphine for treatment of opioid use disorder since 2008, but only 6.1% had dispensed buprenorphine in the month preceding death. Fentanyl/fentanyl analogs were DMI in 1,568 (69.8%) deaths, yet only 3% had received a fentanyl prescription since 2008. The highest concordance in the month preceding death was observed for clonazepam (43.6%). Overall, concordance between CS dispensing history and the drugs involved in poisoning deaths was low, suggesting a need to reevaluate the complex relationships between prescription medication exposure and overdose death and to expand harm reduction interventions both within and outside the healthcare system to reduce drug poisoning mortality.